PCSK9 Calculator
Estimate LDL-C reduction and eligibility for PCSK9 inhibitor therapy.
Result will appear here.
Interpretation & References
PCSK9 inhibitors typically reduce LDL-C by ~50–60% on top of statins. Adjusted for background therapy:
- LDL-C <70 mg/dL: target achieved
- LDL-C ≥70 mg/dL: consider PCSK9 therapy
Reference: Sabatine MS et al., NEJM 2017;376:1713–1722.